Kedudukan dalam Saham
#37811
Idogen AB (publ) is a Swedish biotechnology company specializing in the... Idogen AB (publ) is a Swedish biotechnology company specializing in the development of tolerogenic cell therapies. These innovative treatments are engineered to prevent a patient's immune system from attacking crucial elements, including biological agents, transplanted organs, and the body's own cells or tissues. The company's most advanced product in development is IDO 8, designed for individuals with severe haemophilia A who have developed neutralizing antibodies against their vital coagulation factor VIII treatment. Idogen is also developing IDO T, a tolerogenic cell therapy intended to prevent organ transplant rejection, primarily for kidney transplants, and IDO AID, aimed at treating autoimmune diseases. Established in 2008, the company is headquartered in Lund, Sweden.
Harga Saham
$0.01345907
Disegerakkan terakhir: 2024-07-12
Perubahan (1 hari)
22.16%
Perubahan (1 tahun)
0.00%
Perdagangan Idogen AB (publ) (IDOGEN)
Harga IDOGEN dengan permodalan pasaran b
Modal pasaran bagi Idogen AB (publ)(IDOGEN)
Modal Pasaran: $1.43M
Sehingga August 2026, Idogen AB (publ) mempunyai modal pasaran sebanyak $1.43M. Ini menjadikan Idogen AB (publ) syarikat ke-37811th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Idogen AB (publ) dari 2015 hingga 2026
IDOGEN berbanding dengan 5 teratas yang paling popular stocks
| Harga IDOGEN |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.452T
|
+381,741,842.27%
|
|
|
|
|
$4.490T
|
+314,392,894.12%
|
|
|
|
|
$4.162T
|
+291,453,291.30%
|
|
|
|
|
$3.676T
|
+257,418,856.56%
|
|
|
|
|
$2.833T
|
+198,370,668.95%
|
